​

Eli Lilly (LLY) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

LLY Stock Forecast

Eli Lilly (LLY) stock forecast, based on 45 Wall Street analysts, predicts a 12-month average price target of $1,324.67, with a high of $1,500.00 and a low of $940.00. This represents a 17.84% increase from the last price of $1,124.16.

$550 $740 $930 $1 $1 $1 High: $1500 Avg: $1324.67 Low: $940 Last Closed Price: $1124.16

LLY Stock Rating

Eli Lilly stock's rating consensus is Buy, based on 45 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 33 Buy (73.33%), 9 Hold (20.00%), 3 Sell (6.67%), and 0 Strong Sell (0.00%).

Buy
Total 45 0 3 9 33 Strong Sell Sell Hold Buy Strong Buy

LLY Price Target Upside V Benchmarks

TypeNameUpside
StockEli Lilly17.84%
SectorHealthcare Stocks 15.45%
IndustryDrug Manufacturers - General Stocks9.63%

Price Target Trends

1M3M12M
# Anlaysts11653
Avg Price Target$940.00$1.33K$1.25K
Last Closing Price$1.12K$1.12K$1.12K
Upside/Downside-16.38%18.21%10.78%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 2661841130
Aug, 2651741128
Jul, 2661751130
Jun, 2661851131
May, 2661861-31
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 10, 2026HSBC$940.00$1.12K-16.38%-16.38%
Aug 07, 2026UBS$1.38K$1.18K16.87%22.40%
Aug 06, 2026Cantor Fitzgerald$1.41K$1.18K19.39%25.43%
Aug 06, 2026Morgan Stanley$1.42K$1.17K21.30%26.23%
Aug 06, 2026Mohit BansalWells Fargo$1.33K$1.17K13.69%18.31%
Aug 06, 2026Evan SeigermanBMO Capital$1.40K$1.17K19.67%24.54%
Jul 14, 2026Bernstein$1.39K$1.19K16.87%23.20%
Jul 13, 2026UBS$1.43K$1.19K19.76%26.76%
Jul 13, 2026Guggenheim$1.27K$1.19K7.10%13.24%
Jul 09, 2026UBS$1.37K$1.22K12.10%21.87%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 10, 2026HSBCReduceReducehold
Sep 09, 2026BMO CapitalOutperformOutperformhold
Sep 01, 2026BMO CapitalOutperformBuyupgrade
Aug 06, 2026Cantor FitzgeraldOverweightOverweighthold
Aug 06, 2026Morgan StanleyOverweightOverweighthold
Aug 06, 2026Wells FargoOverweightOverweighthold
Aug 06, 2026BMO CapitalOutperformOutperformhold
Jul 15, 2026CitigroupBuyBuyhold
Jul 14, 2026BernsteinOutperformOutperformhold
Jul 13, 2026UBSBuyBuyhold

Financial Forecast

EPS Forecast

$5 $13 $21 $29 $37 $45 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.85$6.57$5.83$11.76$23.00---
Avg Forecast$8.13$7.64$6.23$12.95$22.49$29.14$34.70$41.01
High Forecast$9.04$8.56$6.58$13.35$27.77$33.34$41.05$43.17
Low Forecast$7.42$6.99$5.86$12.41$21.13$23.61$25.96$39.12
Surprise %-28.04%-14.01%-6.42%-9.19%2.27%---

Revenue Forecast

$25B $39B $53B $67B $81B $95B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$28.32B$28.54B$34.12B$45.04B$65.18B---
Avg Forecast$28.04B$28.59B$33.65B$45.31B$58.51B$70.05B$79.12B$89.33B
High Forecast$30.46B$31.25B$33.90B$45.68B$59.01B$70.10B$79.63B$92.95B
Low Forecast$26.15B$26.74B$33.44B$45.00B$58.02B$70.00B$78.61B$86.17B
Surprise %0.99%-0.17%1.40%-0.58%11.41%---

Net Income Forecast

$0 $8B $16B $24B $32B $40B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.58B$6.24B$5.24B$10.59B$20.64B---
Avg Forecast$5.76B$5.98B$5.24B$11.63B$19.44B$24.80B$30.38B$37.04B
High Forecast$6.92B$7.17B$6.29B$12.06B$25.08B$30.11B$37.08B$39.00B
Low Forecast$4.61B$4.78B$4.19B$11.21B$19.09B$21.33B$23.45B$35.34B
Surprise %-3.15%4.45%--8.95%6.14%---

LLY Forecast FAQ

Is Eli Lilly stock a buy?

Eli Lilly stock has a consensus rating of Buy, based on 45 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 33 Buy, 9 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Eli Lilly is a favorable investment for most analysts.

What is Eli Lilly's price target?

Eli Lilly's price target, set by 45 Wall Street analysts, averages $1.32K over the next 12 months. The price target range spans from $940 at the low end to $1.5K at the high end, suggesting a potential 17.84% change from the previous closing price of $1.12K.

How does Eli Lilly stock forecast compare to its benchmarks?

Eli Lilly's stock forecast shows a 17.84% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the drug manufacturers - general stocks industry (9.63%).

What is the breakdown of analyst ratings for Eli Lilly over the past three months?

  • September 2026: 20.00% Strong Buy, 60.00% Buy, 13.33% Hold, 3.33% Sell, 3.33% Strong Sell.
  • August 2026: 17.86% Strong Buy, 60.71% Buy, 14.29% Hold, 3.57% Sell, 3.57% Strong Sell.
  • July 2026: 20.00% Strong Buy, 56.67% Buy, 16.67% Hold, 3.33% Sell, 3.33% Strong Sell.

What is Eli Lilly’s EPS forecast?

Eli Lilly's average annual EPS forecast for its fiscal year ending in December 2026 is $29.14, marking a 26.70% increase from the reported $23 in 2025. Estimates for the following years are $34.7 in 2027, and $41.01 in 2028.

What is Eli Lilly’s revenue forecast?

Eli Lilly's average annual revenue forecast for its fiscal year ending in December 2026 is $70.05B, reflecting a 7.48% increase from the reported $65.18B in 2025. The forecast for 2027 is $79.12B, and $89.33B for 2028.

What is Eli Lilly’s net income forecast?

Eli Lilly's net income forecast for the fiscal year ending in December 2026 stands at $24.8B, representing an 20.17% increase from the reported $20.64B in 2025. Projections indicate $30.38B in 2027, and $37.04B in 2028.